People · Operator
Named in public records as an officer, director or promoter · active 2013–2023 · Biotechnology, Manufacturing, Healthtech, Other Health Care
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Kyverna Therapeutics, Inc. | — | Biotechnology | Series D+ | $152.0M | $4.0B | 2021 |
| Westwin Elements Inc | — | Manufacturing | Series B | $42.1M | $2.6M | 2022 |
| Florence Healthcare, Inc. | — | Healthtech | Series B | $26.5M | $369.2M | 2019 |
| Spesana Inc. | — | Other Health Care | Seed | $4.8M | $2.8M | 2021 |
| Micropharma Ltd | — | Biotechnology | Pre-Seed | $851K | $47.0M | 2013 |
Ryan Jones at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Ryan Jones on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Carla Balch | 2 | 2 |
| Peter Sobiloff | 1 | 13 |
| Fred Cohen | 1 | 12 |
| Robert Morris | 1 | 7 |
| Michael Cox | 1 | 6 |
| Ian Clark | 1 | 5 |
| Garrett Goldberg | 1 | 4 |
| Andres Garcia | 1 | 3 |
| Steve Liapis | 1 | 3 |
| Jeffrey Muir | 1 | 2 |
| James Chung | 1 | 2 |
| Dennis Muilenburg | 1 | 2 |
| Todd Hembrough | 1 | 2 |
| Jon Rosenbaum | 1 | 2 |
| Karen Walker | 1 | 2 |
| Peter Maag | 1 | 2 |
| Matthew Dicken | 1 | 2 |
| Brian Kotzin | 1 | 2 |
| KaLeigh Long | 1 | 1 |
| Phillip Cochran | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.